Angela A. Armstrong

Array ( [id] => 8784286 [patent_doc_number] => 08431127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => 'Method for treating pruritus comprising administering an NR10 antagonist' [patent_app_type] => utility [patent_app_number] => 12/746229 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10644 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12746229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5435521 [patent_doc_number] => 20090170108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Screening method, a composition comprising substances chosen in the method thereof, and a binding substance' [patent_app_type] => utility [patent_app_number] => 12/315069 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5867 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170108.pdf [firstpage_image] =>[orig_patent_app_number] => 12315069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380233 [patent_doc_number] => 20090192072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Insulin and IGF-1 Receptor Agonists and Antagonists' [patent_app_type] => utility [patent_app_number] => 12/275885 [patent_app_country] => US [patent_app_date] => 2008-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 123 [patent_figures_cnt] => 123 [patent_no_of_words] => 48768 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12275885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487470 [patent_doc_number] => 20110236394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'METHODS FOR THE REGULATION OF THE PROSTAGLANDIN F SYNTHASE (PGFS) ACTIVITY OF AKR1B1 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/743206 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 19827 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236394.pdf [firstpage_image] =>[orig_patent_app_number] => 12743206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479516 [patent_doc_number] => 20090202473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'COMBINATION OF AN ANTI-EDB FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND A MOLECULE BINDING TO B CELLS, B CELL PROGENITORS AND/OR THEIR CANCEROUS COUNTERPART' [patent_app_type] => utility [patent_app_number] => 12/270174 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11759 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202473.pdf [firstpage_image] =>[orig_patent_app_number] => 12270174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6613216 [patent_doc_number] => 20100310454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'COMBINATION OF AN ANTI-EDB FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND A MOLECULE BINDING TO B CELLS, B CELL PROGENITORS AND /OR THEIR CANCEROUS COUNTERPART' [patent_app_type] => utility [patent_app_number] => 12/863417 [patent_app_country] => US [patent_app_date] => 2008-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11534 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310454.pdf [firstpage_image] =>[orig_patent_app_number] => 12863417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546544 [patent_doc_number] => 20090156421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'ASSAYS AND METHODS FOR EVALUATING MULTIMERIC COMPLEXES' [patent_app_type] => utility [patent_app_number] => 12/266126 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 30193 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156421.pdf [firstpage_image] =>[orig_patent_app_number] => 12266126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6644143 [patent_doc_number] => 20100227817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'METABOLIC AND CARDIOPROTECTION BY THE MYOKINE FOLLISTATIN-LIKE 1 POLYPEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/682898 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 24399 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227817.pdf [firstpage_image] =>[orig_patent_app_number] => 12682898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342360 [patent_doc_number] => 20090181010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Arginase II: a target for the prevention of atherosclerosis' [patent_app_type] => utility [patent_app_number] => 12/284723 [patent_app_country] => US [patent_app_date] => 2008-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16802 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181010.pdf [firstpage_image] =>[orig_patent_app_number] => 12284723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5507952 [patent_doc_number] => 20090081159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR DETECTING AND TREATING OPHTHALMIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/234195 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15536 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081159.pdf [firstpage_image] =>[orig_patent_app_number] => 12234195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007072 [patent_doc_number] => 20110059103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'FUTURE CARDIAC EVENT BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 12/677437 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 19248 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059103.pdf [firstpage_image] =>[orig_patent_app_number] => 12677437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6506571 [patent_doc_number] => 20100210538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'THERAPEUTIC USES OF INTERMEDIN 47 AND 53 PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/677731 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34918 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210538.pdf [firstpage_image] =>[orig_patent_app_number] => 12677731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564827 [patent_doc_number] => 20090137680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHOD FOR TREATING BRAIN SWELLING' [patent_app_type] => utility [patent_app_number] => 12/201610 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 62136 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137680.pdf [firstpage_image] =>[orig_patent_app_number] => 12201610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310213 [patent_doc_number] => 20090017494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'TICK OCTOPAMINE RECEPTOR NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/200456 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21949 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017494.pdf [firstpage_image] =>[orig_patent_app_number] => 12200456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5278549 [patent_doc_number] => 20090130681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => '21132, a Human G-protein coupled receptor family member and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/229868 [patent_app_country] => US [patent_app_date] => 2008-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 42267 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130681.pdf [firstpage_image] =>[orig_patent_app_number] => 12229868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585940 [patent_doc_number] => 20090105142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'TREATMENT WITH KALLIKREIN INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/196357 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11664 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105142.pdf [firstpage_image] =>[orig_patent_app_number] => 12196357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272111 [patent_doc_number] => 20090075887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Treatment with Kallikrein Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/194758 [patent_app_country] => US [patent_app_date] => 2008-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12330 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075887.pdf [firstpage_image] =>[orig_patent_app_number] => 12194758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138491 [patent_doc_number] => 20120093798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'Methods for Treatment of Stroke or Cerebrovascular' [patent_app_type] => utility [patent_app_number] => 12/673140 [patent_app_country] => US [patent_app_date] => 2008-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9651 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093798.pdf [firstpage_image] =>[orig_patent_app_number] => 12673140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818519 [patent_doc_number] => 20120065139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'GQ PROTEIN COMPETITIVE INHIBITORY POLYPEPTIDES, PREPARATION METHODS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/058836 [patent_app_country] => US [patent_app_date] => 2008-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10113 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065139.pdf [firstpage_image] =>[orig_patent_app_number] => 13058836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337872 [patent_doc_number] => 20090054336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Binding Agent' [patent_app_type] => utility [patent_app_number] => 12/175582 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 11596 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054336.pdf [firstpage_image] =>[orig_patent_app_number] => 12175582 [rel_patent_id] =>[rel_patent_doc_number] =>)